Harmony Biosciences Holdings, Inc. 13D and 13G filings for Zynerba Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-08-24 5:23 pm Purchase |
2023-08-14 | 13D | Zynerba Pharmaceuticals, Inc. ZYNE |
Harmony Biosciences Holdings Inc. HRMY |
7,592,498 13.130% |
7,592,498 (New Position) |
Filing |